RNA Annual EBIT
-$235.60 M
-$56.69 M-31.68%
31 December 2023
Summary:
As of January 23, 2025, RNA annual earnings before interest & taxes is -$235.60 million, with the most recent change of -$56.69 million (-31.68%) on December 31, 2023. During the last 3 years, it has fallen by -$191.45 million (-433.68%). RNA annual EBIT is now -2144.22% below its all-time high of -$10.12 million.RNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNA Quarterly EBIT
-$98.13 M
-$15.51 M-18.77%
01 September 2024
Summary:
As of January 23, 2025, RNA quarterly earnings before interest & taxes is -$98.13 million, with the most recent change of -$15.51 million (-18.77%) on September 1, 2024. Over the past year, it has dropped by -$39.51 million (-67.39%). RNA quarterly EBIT is now -4407.76% below its all-time high of -$2.18 million, reached on March 31, 2019.RNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNA TTM EBIT
-$324.69 M
-$39.51 M-13.85%
01 September 2024
Summary:
As of January 23, 2025, RNA TTM earnings before interest & taxes is -$324.69 million, with the most recent change of -$39.51 million (-13.85%) on September 1, 2024. Over the past year, it has dropped by -$102.61 million (-46.20%). RNA TTM EBIT is now -14814.56% below its all-time high of -$2.18 million, reached on March 31, 2019.RNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.7% | -67.4% | -46.2% |
| 3 y3 years | -433.7% | -235.2% | -239.0% |
| 5 y5 years | -2144.2% | -1785.0% | -1771.7% |
RNA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.6% | at low | -184.8% | at low | -175.0% | at low |
| 5 y | 5-year | -1258.2% | at low | -1533.7% | at low | -1771.7% | at low |
| alltime | all time | -2144.2% | at low | -4407.8% | at low | <-9999.0% | at low |
Avidity Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$98.13 M(+18.8%) | -$324.69 M(+13.9%) |
| June 2024 | - | -$82.63 M(+7.0%) | -$285.18 M(+11.8%) |
| Mar 2024 | - | -$77.19 M(+15.6%) | -$255.19 M(+8.3%) |
| Dec 2023 | -$235.60 M(+31.7%) | -$66.74 M(+13.8%) | -$235.60 M(+6.1%) |
| Sept 2023 | - | -$58.63 M(+11.4%) | -$222.08 M(+6.6%) |
| June 2023 | - | -$52.63 M(-8.6%) | -$208.38 M(+3.1%) |
| Mar 2023 | - | -$57.60 M(+8.2%) | -$202.05 M(+12.9%) |
| Dec 2022 | -$178.91 M(+51.6%) | -$53.23 M(+18.5%) | -$178.91 M(+8.9%) |
| Sept 2022 | - | -$44.93 M(-3.0%) | -$164.24 M(+10.5%) |
| June 2022 | - | -$46.30 M(+34.4%) | -$148.59 M(+15.5%) |
| Mar 2022 | - | -$34.46 M(-10.6%) | -$128.65 M(+9.0%) |
| Dec 2021 | -$118.05 M | -$38.55 M(+31.6%) | -$118.05 M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$29.28 M(+11.0%) | -$95.78 M(+22.9%) |
| June 2021 | - | -$26.37 M(+10.5%) | -$77.94 M(+25.7%) |
| Mar 2021 | - | -$23.86 M(+46.6%) | -$62.00 M(+40.4%) |
| Dec 2020 | -$44.15 M(+154.5%) | -$16.27 M(+42.3%) | -$44.15 M(+30.1%) |
| Sept 2020 | - | -$11.44 M(+9.7%) | -$33.93 M(+22.5%) |
| June 2020 | - | -$10.43 M(+73.5%) | -$27.70 M(+30.8%) |
| Mar 2020 | - | -$6.01 M(-0.9%) | -$21.18 M(+22.1%) |
| Dec 2019 | -$17.35 M(+65.2%) | -$6.06 M(+16.5%) | -$17.35 M(+53.7%) |
| Sept 2019 | - | -$5.21 M(+33.5%) | -$11.28 M(+85.7%) |
| June 2019 | - | -$3.90 M(+79.2%) | -$6.08 M(+179.2%) |
| Mar 2019 | - | -$2.18 M | -$2.18 M |
| Dec 2018 | -$10.50 M | - | - |
FAQ
- What is Avidity Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Avidity Biosciences?
- What is Avidity Biosciences annual EBIT year-on-year change?
- What is Avidity Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Avidity Biosciences?
- What is Avidity Biosciences quarterly EBIT year-on-year change?
- What is Avidity Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Avidity Biosciences?
- What is Avidity Biosciences TTM EBIT year-on-year change?
What is Avidity Biosciences annual earnings before interest & taxes?
The current annual EBIT of RNA is -$235.60 M
What is the all time high annual EBIT for Avidity Biosciences?
Avidity Biosciences all-time high annual earnings before interest & taxes is -$10.12 M
What is Avidity Biosciences annual EBIT year-on-year change?
Over the past year, RNA annual earnings before interest & taxes has changed by -$56.69 M (-31.68%)
What is Avidity Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of RNA is -$98.13 M
What is the all time high quarterly EBIT for Avidity Biosciences?
Avidity Biosciences all-time high quarterly earnings before interest & taxes is -$2.18 M
What is Avidity Biosciences quarterly EBIT year-on-year change?
Over the past year, RNA quarterly earnings before interest & taxes has changed by -$39.51 M (-67.39%)
What is Avidity Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of RNA is -$324.69 M
What is the all time high TTM EBIT for Avidity Biosciences?
Avidity Biosciences all-time high TTM earnings before interest & taxes is -$2.18 M
What is Avidity Biosciences TTM EBIT year-on-year change?
Over the past year, RNA TTM earnings before interest & taxes has changed by -$102.61 M (-46.20%)